Brillantes, Rosalie .
HRN: 29-10-63 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2026
CEFUROXIME 1.5GM (VIAL)
07/08/2026
07/08/2026
IV
1.5
Q8
UTI
Checking Initial Appropriateness
07/08/2026
CEFUROXIME 500MG (TAB)
07/08/2026
07/15/2026
PO
500
Bid
Uti
Checking Initial Appropriateness